Agendia
Ayesha Usman is an experienced project manager and IT business analyst with a strong background in healthcare technology and product management. Currently at Agendia, Inc. since June 2014, Ayesha has led the market launch of the Next Generation Sequence product in the European Union and China and enhanced cancer patient reports for the SymphonyTM suite. Prior roles include senior business analyst at Dynamic Healthcare Systems, where Ayesha directed the product management team for the 'Agent Commission' module, and product manager at MedAid Consulting LLC, managing the development of the 'eCHDP' product. Ayesha's early career includes positions such as clinic supervisor at Remington Health Center, where significant process improvements were achieved, and software engineer at Techlogix, leading in-house project rollouts. Ayesha holds an MBA in General and Strategic Management from California State Polytechnic University-Pomona and a BS in Computer Science from the National University of Computer and Emerging Sciences.
This person is not in any teams
Agendia
Agendia is the only molecular diagnostics company focused solely on breast cancer. With their groundbreaking genomic testing, they generate reliable and meaningful clinical data about the unique biology of a woman’s breast cancer.